Tyson Foods Total Cost of Revenue decreased by 6.0% to $12.69B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 1.7%, from $12.47B to $12.69B. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows an upward trend with a 5.9% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $10.86B | $10.34B | $10.92B | $11.38B | $11.88B | $12.43B | $12.29B | $12.61B | $12.46B | $12.89B | $12.50B | $12.21B | $12.48B | $12.51B | $12.53B | $12.47B | $12.74B | $13.13B | $13.51B | $12.69B |
| QoQ Change | — | -4.8% | +5.6% | +4.2% | +4.4% | +4.6% | -1.1% | +2.6% | -1.1% | +3.4% | -3.0% | -2.3% | +2.2% | +0.2% | +0.2% | -0.4% | +2.2% | +3.1% | +2.8% | -6.0% |
| YoY Change | — | — | — | — | +9.4% | +20.3% | +12.6% | +10.8% | +4.9% | +3.7% | +1.7% | -3.2% | +0.1% | -3.0% | +0.3% | +2.2% | +2.1% | +5.0% | +7.8% | +1.7% |